VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 59 filers reported holding VOR BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $445,000 | -89.3% | 111,808 | -86.6% | 0.01% | -89.3% |
Q2 2022 | $4,142,000 | -17.7% | 833,333 | 0.0% | 0.08% | -8.5% |
Q1 2022 | $5,033,000 | -48.0% | 833,333 | 0.0% | 0.08% | -33.9% |
Q4 2021 | $9,683,000 | -25.9% | 833,333 | 0.0% | 0.12% | -13.9% |
Q3 2021 | $13,067,000 | -15.9% | 833,333 | 0.0% | 0.14% | -8.3% |
Q2 2021 | $15,542,000 | -56.7% | 833,333 | 0.0% | 0.16% | -53.3% |
Q1 2021 | $35,917,000 | – | 833,333 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 6,692,429 | $288,444,000 | 51.94% |
Trustees of Columbia University in the City of New York | 183,821 | $7,923,000 | 9.60% |
RA Capital Management | 11,120,973 | $479,314,000 | 7.23% |
Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $46,318,000 | 6.00% |
Sarissa Capital Management LP | 707,010 | $30,472,000 | 2.92% |
SECTORAL ASSET MANAGEMENT INC | 535,259 | $23,070,000 | 1.75% |
Woodline Partners LP | 1,153,267 | $49,706,000 | 1.10% |
Artal Group S.A. | 550,000 | $23,705,000 | 0.42% |
Orbimed Advisors | 833,333 | $35,917,000 | 0.34% |
Laurion Capital Management LP | 585,667 | $25,242,000 | 0.14% |